DOGS · Condition guide
Atopic dermatitis in dogs: real veterinary cases
Canine atopic dermatitis is a lifelong allergic skin disease — the dog's immune system reacts to ordinary environmental allergens like pollens, dust mites, and moulds. It usually starts between 6 months and 3 years of age, often shows clear seasonality at first, and over time progresses to year-round itching with recurrent ear and skin infections.
Diagnosis is clinical and one of exclusion: rule out fleas, mites, and food allergy, then what's left is atopy. Modern treatment is a multi-modal toolkit — symptomatic relief (Apoquel, Cytopoint, steroids), barrier support (omega-3s, medicated shampoos), and disease-modifying allergen-specific immunotherapy (ASIT). Most dogs do very well long-term.
What vets typically check for
- Rigorous flea control (isoxazolines, year-round) — fleas are still the #1 missed cause.
- 8-week strict elimination diet to rule out adverse food reaction.
- Treat any concurrent skin or ear infections (Staph, Malassezia).
- Once atopy is confirmed: choose between symptomatic (Apoquel, Cytopoint) and disease-modifying (immunotherapy).
- Intradermal or serological allergy testing to formulate immunotherapy if elected.
Not a replacement for veterinary care. Use this to walk into the conversation prepared, not to self-diagnose.
Real cases from the veterinary literature
Peer-reviewed reports our semantic search surfaces for Canine atopic dermatitis. Click into any case for the full abstract — or run a personalised search with your pet's exact details.
- Case report: an ‘atypical’ atopic
Companion Animal · 2014 · United States
A 20-month-old spayed female Labrador was taken to a specialist for skin issues that suggested she might have a sensitivity disorder. After several tests, she was diagnosed with atopic dermatitis (a skin condition caused by allergies). Despite trying various treatments, including antihistamines, immunotherapy, cyclosporine, and steroids, she continued to experience intense itch
- Oclacitinib (APOQUEL®) is a selective Janus kinase 1 inhibitor with efficacy in a canine model of flea allergic dermatitis.
Journal of veterinary pharmacology and therapeutics · 2024 · United States
Oclacitinib, also known as Apoquel, is a new medication that helps reduce itching and inflammation in dogs with flea allergy dermatitis, a condition where dogs have allergic reactions to flea bites. In a study, dogs were given either a single dose or a dose twice daily for two weeks, and researchers found that the medication significantly decreased itching within just 1.5 hours
- A case of presumed autoimmune subepidermal blistering dermatosis treated with oclacitinib
Veterinary Dermatology · 2017 · France
BackgroundAutoimmune subepidermal blistering dermatoses (ASBD) are a group of severe autoimmune dermatoses rarely described in dogs. Their treatment usually necessitates the long term use of medications potentially associated with adverse effects. In humans, Janus Kinase (JAK) inhibitors have been demonstrated to be of value in some cases of autoimmune skin disease. Hypothesi
- Small animal Review
Companion Animal · 2020 · United States
This study looked at how to manage allergic skin conditions in dogs, which can be treated with various medications, including oclacitinib. Oclacitinib works by blocking certain proteins that cause inflammation, but it may also affect how cells grow and survive. The researchers wanted to find out if using oclacitinib for a long time could increase the risk of cancer in dogs. The
- An update on the treatment of canine atopic dermatitis.
Veterinary journal (London, England : 1997) · 2016 · United States
Canine atopic dermatitis is a common skin condition in dogs that causes inflammation and intense itching. Various factors can make the symptoms worse, such as fleas, bacterial or yeast infections, and food allergies. While fleas don’t cause the condition, they can aggravate the itching, so it's important to keep your dog protected from them. Treatment usually starts with addres
Frequently asked questions
- What's the difference between Apoquel and Cytopoint?
- Apoquel (oclacitinib) is a daily oral JAK-inhibitor — fast onset, very effective. Cytopoint (lokivetmab) is a monthly injectable monoclonal antibody specifically against canine IL-31. Many dogs do well on either; some respond better to one than the other.
- Does immunotherapy work?
- It's the only treatment that actually modifies the disease rather than masking the itch. Roughly 60-70% of dogs improve significantly on a properly-formulated immunotherapy course given over months to years. It's a long game but worth it for many cases.
- Will diet change cure it?
- Only if the dog has a concurrent food allergy. Most atopic dogs are not primarily food-allergic, but ~20% have both. A proper diet trial rules food in or out and is always step one.